Clinical trial · Interventional
Effect of Probiotics in Patients Undergoing Surgery for Periampullary Neoplasms
Effect of the Probiotics Use in Patients Undergoing Surgery for Periampullary Neoplasia - A Randomized Clinical Trial
NCT01468779CI-TRIAL-00026227completedPhase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to evaluate the effect of the probiotic use in patients with periampullary cancers undergone curative or palliative treatment considering nutritional status, postoperative complications, infection rate, length of hospitalization and mortality.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Periampullary Carcinoma Nos | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Probiotics | Dietary Supplement | — | UNRESOLVED |
| Sugar pill | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- PLACEBO_COMPARATOR
- label
- Sugar pill
- description
- The patients submitted to periampullary cancer surgery will receive sugar pills in the preoperative and postoperative period.
- interventionNames
- Dietary Supplement: Sugar pill
- type
- ACTIVE_COMPARATOR
- label
- Probiotics
- description
- The probiotics pills are given orally in the amount of two pills twice a day as early as two days before surgery until ten days after surgery.
- interventionNames
- Dietary Supplement: Probiotics
Primary outcomes (1)
- measure
- Mortality
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients in need of surgery for periampullary cancer Exclusion Criteria: * Patients submitted to periampullary surgery without pathologic confirmation of cancer * Patients unwilling to be a part of the trial
References
Publications (0)
Data not yet available
No reference posted for this study.